Ownership history in MACQUARIE GROUP LTD · 30 quarters on record
This page tracks every 13F SEC filing in which MACQUARIE GROUP LTD reported a position in MADRIGAL PHARMACEUTICALS INC (MDGL). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q3 | REDUCED | 13,493 | -6,150 | -31.3% | 0.01% | $6.2M | $458.66 |
| 2025 Q2 | ADDED | 19,643 | +4,643 | +31.0% | 0.01% | $5.9M | $302.64 |
| 2025 Q1 | UNCHANGED | 15,000 | — | 0% | 0.01% | $5.0M | $331.23 |
| 2024 Q4 | UNCHANGED | 15,000 | — | 0% | 0.01% | $4.6M | $308.57 |
| 2024 Q3 | REDUCED | 15,000 | -13,500 | -47.4% | 0.00% | $3.2M | $212.22 |
| 2024 Q2 | REDUCED | 28,500 | -30,457 | -51.7% | 0.01% | $8.0M | $280.16 |
| 2024 Q1 | ADDED | 58,957 | +30,457 | +106.9% | 0.02% | $15.7M | $267.04 |
| 2023 Q4 | UNCHANGED | 28,500 | — | 0% | 0.01% | $6.6M | $231.38 |
| 2023 Q3 | UNCHANGED | 28,500 | — | 0% | 0.01% | $4.2M | $146.04 |
| 2023 Q2 | UNCHANGED | 28,500 | — | 0% | 0.01% | $6.6M | $231.00 |
As of 2025 Q4 — sorted by position size